Point72 Middle East FZE’s Zimmer Biomet ZBH Stock Holding History

Point72 Middle East FZE’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-58,936	Closed	-$6.61M	–	1935
2023 Q3	$6.61M	Buy	+58,936	New	+$7.48M	0.22%	113

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Middle East FZE's ZBH Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 58,936 shares — an estimated $6.61M sold.

Point72 Middle East FZE first reported a position in ZBH in Q3 2023 and held it in 1 quarter. The position peaked at $6.61M in Q3 2023. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

Point72 Middle East FZE reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
Point72 Middle East FZE sold 58,936 Zimmer Biomet shares in Q4 2023, an estimated $6.61M.
Point72 Middle East FZE first reported a position in Zimmer Biomet in Q3 2023 and held it in 1 quarter.
Point72 Middle East FZE's Zimmer Biomet position peaked at $6.61M in Q3 2023.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.